Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference

Rhea-AI Summary

Amicus Therapeutics (FOLD) has announced its participation in the Bank of America 2025 Health Care Conference in Las Vegas. The company's management will engage in a fireside chat on Wednesday, May 14, 2025, at 8:00 a.m. PT. Investors and interested parties can access a live audio webcast of the presentation through the investors section of Amicus Therapeutics' corporate website.

Amicus Therapeutics is a global biotechnology company dedicated to discovering, developing, and delivering innovative medicines for rare diseases, with a strong focus on patient care and advancing their pipeline of first- or best-in-class treatments.

News Market Reaction – FOLD

-1.62%

-1.62% Session move

In the trading session that priced this news, FOLD declined 1.62%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2025 Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2025, at 8:00 a.m. P.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When is Amicus Therapeutics (FOLD) presenting at the Bank of America Healthcare Conference 2025?

Amicus Therapeutics will present at the Bank of America Healthcare Conference on Wednesday, May 14, 2025, at 8:00 a.m. PT in Las Vegas, NV.

How can investors watch Amicus Therapeutics' (FOLD) presentation at the Bank of America conference?

Investors can watch the live audio webcast through the investors section of Amicus Therapeutics' corporate website at https://ir.amicusrx.com/events-and-presentations.

What is the main focus of Amicus Therapeutics (FOLD) as a company?

Amicus Therapeutics is a global biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases.

Who are the key contacts for Amicus Therapeutics (FOLD) investor relations?

Andrew Faughnan serves as Vice President of Investor Relations and can be contacted at afaughnan@amicusrx.com or (609) 662-3809.